Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Sun Pharma Says Partner Philogen's Phase II Flash Study In Soft Tissue Sarcoma Did Not Meet Primary Endpoint

March 27 (Reuters) - SUN PHARMA:

PARTNER PHILOGEN'S PHASE II FLASH STUDY IN SOFT TISSUE SARCOMA DID NOT MEET PRIMARY ENDPOINT

PHILOGEN'S PHASE II GLIOSTAR TRIAL IN GLIOBLASTOMA DID NOT MEET PRIMARY ENDPOINT

PHILOGEN REMAINS COMMITTED TO EXECUTION OF GLIOSUN CLINICAL TRIAL

Source text: ID:nBSE70fvgH

Further company coverage: PHIL.MI

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sun Pharmaceutical Industries

See all news